22nd Century Group Inc (USD)
XXII
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.00 | 1.05
52-Wk Range0.70 | 3.12
Last Close1.02
Mkt Cap (m)135.79
Dividend yield-
ISINUS90137F1030
Volume294,545
Exchange VenueASE

Company Profile

22nd Century Group Inc is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.

Key Information
Price/Earning-
Price/Book2.46
Price/Sales4.95
P/CF-
Rev Growth (3 year avg)45.83
EPS Growth (3 year avg)-
Operating Margin % -90.89
Net Margin %-30.15
Return on Equity-10.86
Debt/Equity0.02

Legal Documents

Prospectus
en 26/11/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)719121726
Operating Income (m)2-12-12-11-13-24
Net Income (m)-26-16-11-12-13-8
Basic EPS-0.60-0.26-0.16-0.15-0.13-0.06
Avg. Diluted Shares Outstanding (m)44606880101124
Balance Sheet
USD201320142015201620172018
Current Assets (m)8117176861
Non Current Assets (m)51111111216
Total Assets (m)122218288077
Current Liabilities (m)133345
Total Liabilities (m)------
Total Equity (m)81512247571
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)4-7-7-10-12-18
Capital Expenditure (m)-4-2-1-2-1
Figures are quoted in USD unless stated otherwise
-0.02 (-1.47%)
$
1.01
Last Price